41 results
Page 2 of 3
6-K
8ykiu3op6l577u f1i
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
n6xif0awsfuyewu3jr
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.2
zq6xs52jjsbt gbt3o
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
je1bgzb 77u8
24 Oct 16
Bioblast Announces Results of Trehalose Clinical Study
12:00am
424B5
pwa1hv
18 Mar 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
jqmho
27 Oct 15
Current report (foreign)
12:00am
6-K
EX-99.1
0zuld 3nxt6
27 Oct 15
Current report (foreign)
12:00am
20-F
tdwyx 1nj
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
ynlxfr51hmo724
10 Feb 15
Notice of Extraordinary General Meeting of Shareholders
12:00am
6-K
EX-99.1
x6utb20taq55b x6iuk4
8 Jan 15
Current report (foreign)
12:00am
6-K
EX-99.1
yi11511i mrkhf
22 Sep 14
Bio Blast Pharma Announces Initiation of its Canadian OPMD Clinical Study Center at McGill University, Montreal
12:00am
6-K
EX-99.1
uhutffb753
17 Sep 14
BioBlast Pharma Announces Preclinical and Clinical Pharmacokinetic Results with Cabaletta, Interim Safety Results from Phase 2/3HOPEMD Study in OPMD
12:00am
424B4
vyx8ut 04cc8nnq6
31 Jul 14
Prospectus supplement with pricing info
12:00am